REBEKAH COSTELLO: Open Payments
NPI 1518681006 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 26 payments from 17 companies in 2025. Trend: 2023 $638 · 2024 $808 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $139 |
| Actelion Pharmaceuticals US, Inc. | 1 | $127 |
| Mallinckrodt Hospital Products Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $105 |
| Smith+Nephew, Inc. | 1 | $102 |
| Vifor Pharma, Inc. | 4 | $98 |
| SCPHARMACEUTICALS INC. | 2 | $47 |
| Lilly USA, LLC | 2 | $43 |
Products named: JARDIANCE, WATCHMAN FLX, UPTRAVI, TERLIVAZ, QULIPTA, REXULTI, COLLAGENASE SANTYL, Veltassa.
Industry payments across FL — which companies pay providers there.
